Company Legal Name
Latest Valuation
Founded Year
Headquarter
Suki AI, Inc. develops voice-enabled artificial intelligence scribe software that automates clinical documentation for healthcare providers, streamlining administrative workflows in medical practices. Founded in 2017 and headquartered in Redwood City, the company has positioned itself as a leading solution in the AI medical scribes market by reducing documentation time and improving physician productivity. Suki has achieved a $500 million valuation, reflecting strong investor confidence in its technology and market opportunity. The company continues to focus on expanding its AI capabilities and healthcare provider partnerships, addressing the critical need for administrative efficiency in an increasingly burdened healthcare system.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





